We’re proud to share that miDiagnostics has been awarded MedTech Company of the Year – Breakthrough Diagnostic Technology | Europe in Business Worldwide Magazine’s 2026 Global Corporate Excellence Awards.
This recognition reflects the dedication, expertise, and passion of our entire team. Every day, we work toward one goal: helping accelerate access to life-changing therapies through faster, reliable diagnostic solutions.
This recognition becomes even more meaningful with the acknowledgment of our CEO, Dr. Katleen Verleysen, whose leadership has been instrumental in guiding miDiagnostics through a period of rapid growth, innovation, and global impact.
Our ultra-fast PCR technology is transforming sterility testing in advanced therapy manufacturing, reducing testing times from days to under two hours. By enabling faster release of critical treatments such as CAR-T therapies, we are helping our partners deliver innovative treatments to patients when time matters most.
We are grateful for this recognition, as it motivates us to continue pushing the boundaries of diagnostic innovation.
Read the full press release here.
